Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease
出版年份 2015 全文链接
标题
Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease
作者
关键词
Bone turnover markers, Dickkopf-1, Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Sclerostin
出版物
JOURNAL OF BONE AND MINERAL METABOLISM
Volume 34, Issue 4, Pages 447-456
出版商
Springer Nature
发表日期
2015-06-11
DOI
10.1007/s00774-015-0687-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Relationships Between Serum Sclerostin, Bone Mineral Density, and Vascular Calcification in Rheumatoid Arthritis
- (2014) J. Paccou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles?
- (2014) R. Sapir-Koren et al. OSTEOPOROSIS INTERNATIONAL
- Relationship of Dickkopf1 (DKK1) with Cardiovascular Disease and Bone Metabolism in Caucasian Type 2 Diabetes Mellitus
- (2014) Antonia Garcia-Martín et al. PLoS One
- Preliminary mechanism on the methylation modification of Dkk-1 and Dkk-3 in hepatocellular carcinoma
- (2014) Libo Liang et al. TUMOR BIOLOGY
- Circulating Dickkopf‐1 in Diabetes Mellitus: Association With Platelet Activation and Effects of Improved Metabolic Control and Low‐Dose Aspirin
- (2014) Stefano Lattanzio et al. Journal of the American Heart Association
- Serum Sclerostin in Alcoholics: A Pilot Study
- (2013) E. González-Reimers et al. ALCOHOL AND ALCOHOLISM
- Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity
- (2013) K.-H. William Lau et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study
- (2013) Stergios A. Polyzos et al. BIOMARKERS
- The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women
- (2013) Geeta Hampson et al. BONE
- Involvement of WNT/β-catenin Signaling in the Treatment of Osteoporosis
- (2013) Maurizio Rossini et al. CALCIFIED TISSUE INTERNATIONAL
- The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus
- (2013) Agostino Gaudio et al. Diabetes & Vascular Disease Research
- Extrahepatic complications of nonalcoholic fatty liver disease
- (2013) Matthew J. Armstrong et al. HEPATOLOGY
- Effect of liver dysfunction on circulating sclerostin
- (2013) Yumie Rhee et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Serum sclerostin levels in healthy men over 50 years of age
- (2013) Harjit Pal Bhattoa et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin and Dickkopf-1 Levels of Naive Postmenopausal Women With Low Bone Mass: A Randomized, Head-to-Head Clinical Trial
- (2013) Athanasios D. Anastasilakis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups
- (2013) Mark M Smits et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease
- (2013) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver
- (2013) Giovanni Musso et al. TRENDS IN MOLECULAR MEDICINE
- Role of wingless tail signaling pathway in osteoporosis
- (2013) Athanasios D. Anastasilakis et al. Current Opinion in Endocrinology Diabetes and Obesity
- Review article: non-alcoholic fatty liver disease and osteoporosis - clinical and molecular crosstalk
- (2012) Y. Yilmaz ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- High Circulating Sclerostin is Present in Patients with Thalassemia-associated Osteoporosis and Correlates with Bone Mineral Density
- (2012) E. Voskaridou et al. HORMONE AND METABOLIC RESEARCH
- Association between Nonalcoholic Fatty Liver Disease (NAFLD) and Osteoporotic Fracture in Middle-Aged and Elderly Chinese
- (2012) Mian Li et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Nonalcoholic Fatty Liver Disease
- (2012) Stergios A. Polyzos et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease
- (2012) Tugrul Purnak et al. WIENER KLINISCHE WOCHENSCHRIFT
- Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children
- (2011) P. E. Pardee et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide
- (2011) S. A. Polyzos et al. OSTEOPOROSIS INTERNATIONAL
- Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
- (2010) Judith Ertle et al. INTERNATIONAL JOURNAL OF CANCER
- Insulin receptor expression in bone
- (2010) D. M. Thomas et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines
- (2009) Stergios Polyzos et al. CURRENT MOLECULAR MEDICINE
- Wnt signaling in development and disease
- (2009) Jennifer L. Freese et al. NEUROBIOLOGY OF DISEASE
- The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
- (2008) Mariana Lazo et al. SEMINARS IN LIVER DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now